Leo Lee
Nanoscience and Nanotechnology
 Regeneus
Australia
Biography
Leo has served on the Board since December 2017. Leo is a Senior executive with over 20 years of experience in Pharmaceutical innovation, commercialisation, regulatory and policy. He has worked in North America, Asia and has lived and worked in Japan the last 12 years. Leo was previously President of Allergan, Japan and is currently President of Merck Japan.
Research Interest
Nanoscience and Nanotechnology